EyePoint Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1987-01-01
- Employees
- 121
- Market Cap
- $486.4M
- Introduction
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors
EyePoint Pharmaceuticals appoints Dr. Reginald J. Sanders to its Board, enhancing its focus on innovative therapeutics for retinal diseases. Dr. Sanders brings extensive experience in ophthalmology and retina research, supporting EyePoint's clinical trials for treatments like DURAVYU for wet AMD and diabetic macular edema.
© Copyright 2025. All Rights Reserved by MedPath